Glycerin

Glycerin

SCHEMBL4353792

OCC(O)CO.[Cl-].[Cl-].[Mg+2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Glycerin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL29169402 0.96 LMNA (0.75)
Glycerin SCHEMBL3951821 0.95
Glycerin SCHEMBL1193773 0.91
Glycerin SCHEMBL21465332 0.91 LMNA (0.82)
Glycerin SCHEMBL3296195 0.91
Glycerin SCHEMBL25424895 0.91
Glycerin SCHEMBL9460329 0.91
Glycerin SCHEMBL19689532 0.91
Glycerin SCHEMBL11026689 0.91
Glycerin SCHEMBL19125718 0.91 LMNA (0.82)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116370656-A Exosome ferroferric oxide nano probe and preparation method and application thereof 宁波大学附属第一医院 2023-07-04 CN claimed
CN-119687644-A Ammonia system refrigeration house composite system with biomass energy multi-cycle utilization function 常州大学 2025-03-25 CN disclosed
CN-116370656-A Exosome ferroferric oxide nano probe and preparation method and application thereof 宁波大学附属第一医院 2023-07-04 CN disclosed
CN-217499252-U Nasal meatus adhesive virus collecting device 宁波奉化科创科技服务有限公司 2022-09-27 CN disclosed
CN-108841848-B Expression system 富士胶片戴奥辛思生物技术英国有限公司 2022-03-29 CN disclosed
US-20210348205-A1 Expression System FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) 2021-11-11 US disclosed
CN-102690834-B Expression system 富士胶片戴奥辛思生物技术英国有限公司 2018-09-04 CN disclosed
US-20170240943-A1 Expression System FUJIFILM DIOSYNTH BIOTECHNOLOGIES (GB) 2017-08-24 US disclosed
US-9677103-B2 Expression system FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) 2017-06-13 US disclosed
US-20140065670-A1 Expression System FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) 2014-03-06 US disclosed
US-8530188-B2 Expression system Fujifilm Diosynth Biotechnologies (UK) Limited (GB) 2013-09-10 US disclosed
CN-102690834-A Expression system AVECIA BIOLOG LTD 2012-09-26 CN disclosed
CN-101410523-B Expression system AVECIA BIOLOG LTD 2012-05-16 CN disclosed
CN-101935849-B Preparation method of choline chloride type magnesium eutectic solvent QINGHAI INST SALT LAKES CAS 2011-12-21 CN disclosed
CN-101935849-A Preparation method of choline chloride type magnesium eutectic solvent QINGHAI INST SALT LAKES CAS 2011-01-05 CN disclosed
US-20090170160-A1 Expression System FUJIFILM DIOSYNTH BIOTECHNOLOGIES UK LIMITED (GB) 2009-07-02 US disclosed
CN-101410523-A Expression system AVECIA BIOLOG LTD (GB) 2009-04-15 CN disclosed
US-4980194-A Systemic infusion of aqueous solution of retardant WEYERHAEUSER COMPANY (US) 1990-12-25 US disclosed
US-4917922-A UNIFORMLY DISTRIBUTED WITH ACTIVE XYLEM AND FOLTAGE WEYERHAEUSER COMPANY (US) 1990-04-17 US disclosed
EP-0314138-A1 Flame retardant plant WEYERHAEUSER COMPANY (US) 1989-05-03 EP disclosed